Literature DB >> 24302430

Controversies in prenatal diagnosis 3: should everyone undergoing invasive testing have a microarray?

John A Crolla1, Ronald Wapner, Jan M M Van Lith.   

Abstract

Mesh：

Year:  2014        PMID： 24302430     DOI： 10.1002/pd.4287

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  10 in total

1.  An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing.

Authors:  Barbara A Bernhardt; Katherine Kellom; Alexandra Barbarese; W Andrew Faucett; Ronald J Wapner
Journal:  J Genet Couns       Date:  2014-02-27       Impact factor: 2.537

2.  Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing.

Authors:  Sarah A Walser; Katherine S Kellom; Steven C Palmer; Barbara A Bernhardt
Journal:  Prenat Diagn       Date:  2015-06-19       Impact factor: 3.050

Review 3.  Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.

Authors:  Jill Fonda Allen; Katie Stoll; Barbara A Bernhardt
Journal:  Semin Perinatol       Date:  2015-12-21       Impact factor: 3.300

4.  "Something Extra on Chromosome 5": Parents' Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results.

Authors:  Sarah A Walser; Allison Werner-Lin; Amita Russell; Ronald J Wapner; Barbara A Bernhardt
Journal:  J Genet Couns       Date:  2016-03-04       Impact factor: 2.537

5.  Offering pregnant women different levels of genetic information from prenatal chromosome microarray: a prospective study.

Authors:  Jane L Halliday; Cecile Muller; Taryn Charles; Fiona Norris; Joanne Kennedy; Sharon Lewis; Bettina Meiser; Susan Donath; Zornitza Stark; George McGillivray; Melody Menezes; Sian K Smith; Della Forster; Susan Walker; Mark Pertile; David J Amor
Journal:  Eur J Hum Genet       Date:  2018-02-06       Impact factor: 4.246

6.  A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings.

Authors:  Joo Wook Ahn; Susan Bint; Melita D Irving; Phillipa M Kyle; Ranjit Akolekar; Shehla N Mohammed; Caroline Mackie Ogilvie
Journal:  PeerJ       Date:  2014-04-22       Impact factor: 2.984

Review 7.  Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario.

Authors:  Shubha R Phadke; Ratna D Puri; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

8.  Is prenatal cytogenetic diagnosis with genomic array indicated in pregnancies at risk for a molecular or metabolic disorder?

Authors:  Malgorzata I Srebniak; Lutgarde C P Govaerts; Karin E M Diderich; Marieke Joosten; Femke A T de Vries; Robert-Jan H Galjaard; Diane Van Opstal
Journal:  Genet Med       Date:  2015-07-09       Impact factor: 8.822

Review 9.  Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis.

Authors:  Francesca Romana Grati
Journal:  J Clin Med       Date:  2014-07-24       Impact factor: 4.241

Review 10.  Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis.

Authors:  Gioia Mastromoro; Daniele Guadagnolo; Nader Khaleghi Hashemian; Enrica Marchionni; Alice Traversa; Antonio Pizzuti
Journal:  Diagnostics (Basel)       Date:  2022-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.